Corbus Pharmaceuticals Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IFP ADVISORS, INC | 04/18/2023 | 100 | $595 | -75.00% | 0.00% |
| SYNOVUS FINANCIAL CORP | 05/11/2023 | 0 | $0 | -100.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/18/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 07/14/2023 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| PINNACLE ASSOCIATES LTD | 05/05/2023 | 0 | $0 | -100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| COMERICA SECURITIES,INC. | 04/27/2023 | 0 | $0 | -100.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 05/11/2023 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 04/11/2023 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| TEKLA CAPITAL MANAGEMENT LLC | 05/10/2023 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| HBK SORCE ADVISORY LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 05/09/2023 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 05/10/2023 | 0 | $0 | -100.00% | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 05/11/2023 | 0 | $0 | -100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 05/11/2023 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
| SIGMA PLANNING CORP | 05/08/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| SANDY SPRING BANK | 05/05/2023 | 0 | $0 | -100.00% | 0.00% |
| HIGHTOWER ADVISORS, LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| B. RILEY WEALTH ADVISORS, INC. | 05/17/2023 | 0 | $0 | -100.00% | 0.00% |
| NEUBERGER BERMAN GROUP LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| HAP TRADING, LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/09/2023 | 0 | $0 | -100.00% | 0.00% |
| CUTLER GROUP LLC / CA | 05/01/2023 | 0 | $0 | -100.00% | 0.00% |
| CREATIVE PLANNING | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 05/20/2024 | 0 | $0 | -100.00% | 0.00% |
| MCADAM, LLC | 04/24/2023 | 0 | $0 | -100.00% | 0.00% |
| ARIES WEALTH MANAGEMENT | 04/11/2023 | 0 | $0 | -100.00% | 0.00% |
Corbus Pharmaceuticals Holdings, Inc.institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Corbus Pharmaceuticals Holdings, Inc.. The most heavily invested institutionals were:
Kingsbury Capital Investment Advisors LLC: 33,700
American Portfolios Advisors: 2,312
EXANE DERIVATIVES: 2,650
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 0
Investors Financial Group, LLC: 0
Berman Capital Advisors, LLC: 0
0.00% of Corbus Pharmaceuticals Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.07 M shares in the last 24 months. This purchase volume represents approximately $14.04 M in transactions.